Literature DB >> 8806535

Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene.

N Charpentier1, M Dávila, E Domingo, C Escarmís.   

Abstract

During serial undiluted passage of a clonal population of foot-and-mouth disease virus (FMDV C-S8c1) in BHK-21 cells, two species of defective RNA were generated and selected. Sequence analysis revealed that they included deletions within the L-coding region, and retained the correct reading frame for viral protein synthesis. These deleted RNAs directed the synthesis of capsid protein VP1, were packaged in particles sedimenting with standard virus, required homologous infectious helper virus in order to produce viral particles, but did not interfere with the replication of helper virus. While detection of defective particles in FMDV required more than 100 serial passages, once produced, these defective RNAs could be stably maintained upon further passages in the FMDV C-S8c1 quasispecies. Furthermore, a high fitness, monoclonal-antibody-resistant virus was able to replace the standard virus and support the amplification of the deleted particles. This is the first description of naturally occurring, defective particles of FMDV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806535     DOI: 10.1006/viro.1996.0450

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Molecular epidemiology of the foot-and-mouth disease virus outbreak in the United Kingdom in 2001.

Authors:  Eleanor M Cottam; Daniel T Haydon; David J Paton; John Gloster; John W Wilesmith; Nigel P Ferris; Geoff H Hutchings; Donald P King
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Competition-colonization dynamics in an RNA virus.

Authors:  Samuel Ojosnegros; Niko Beerenwinkel; Tibor Antal; Martin A Nowak; Cristina Escarmís; Esteban Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

4.  Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.

Authors:  E Baranowski; C M Ruiz-Jarabo; N Sevilla; D Andreu; E Beck; E Domingo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 5.  Evolutionary transitions during RNA virus experimental evolution.

Authors:  Santiago F Elena
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-19       Impact factor: 6.237

6.  High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus.

Authors:  M Trottier; P Kallio; W Wang; H L Lipton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain.

Authors:  Julie K Pfeiffer; Karla Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

8.  Evolutionary transition toward defective RNAs that are infectious by complementation.

Authors:  Juan García-Arriaza; Susanna C Manrubia; Miguel Toja; Esteban Domingo; Cristina Escarmís
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Resistance of virus to extinction on bottleneck passages: study of a decaying and fluctuating pattern of fitness loss.

Authors:  Ester Lázaro; Cristina Escarmís; Juan Pérez-Mercader; Susanna C Manrubia; Esteban Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

10.  Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response.

Authors:  Lisa J Harwood; Heidi Gerber; Francisco Sobrino; Artur Summerfield; Kenneth C McCullough
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.